Hong Kong scientists flag functional cure for HIV

A team of researchers in Hong Kong say they may have found a functional cure to the virus that causes the AIDS infection.

A health worker collects blood samples for HIV testing.

A health worker collects blood samples for HIV testing. Source: Getty

A research team at Hong Kong University's AIDS Institute says it may have found a "functional cure" to HIV, the virus that causes AIDS, in a major breakthrough that could see a new antibody be used for both prevention and treatment.

The research by the team led by Professor Chen Zhiwei comes as China is facing a growing epidemic issue among high risk groups, including gay men and sex workers.

There are believed to be about 850,000 HIV-infected people in China.

The HIV virus disables the immune system and makes people far more vulnerable to infections and disease.

Chen's discovery, which has been tested on mice, shows that the new antibody can help control the virus and eliminate infected cells.

The antibody would be able to treat all varieties of HIV - a first, Chen said - as there is no one vaccine to treat the many different types of HIV viruses.

"For our newly discovered bispecific antibody, it works for all of them, so that's the major difference," Chen told Reuters.




Chen said a "functional cure" means the virus level would be so low as to be undetectable in the body, as long as people continued taking injections of the antibody, perhaps on a quarterly basis, or less frequently.

The findings by Chen's team have been published in the Journal of Clinical Investigation, one of the world's leading biomedical journals.

People infected with HIV can keep the virus under control with antiretroviral drugs, which stop the virus from infecting new cells.

However, treatments must be taken daily and do not eliminate the infected cells from the body. The virus can, therefore, still exist and come back if patients stop taking their medication properly.

Chen and his team say they are aiming to bring the antibody into clinical trials and give a time frame of three to five years.


Share

2 min read

Published

Updated



Share this with family and friends


Get SBS News daily and direct to your Inbox

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS News
SBS Audio
SBS On Demand

Listen to our podcasts
An overview of the day's top stories from SBS News
Interviews and feature reports from SBS News
Your daily ten minute finance and business news wrap with SBS Finance Editor Ricardo Gonçalves.
A daily five minute news wrap for English learners and people with disability
Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service
Watch the latest news videos from Australia and across the world